JPRN-UMIN000006291已完成未知
Comparison of response to salmeterol/fluticasone combination (SFC) therapy in elderly- versus younger- onset asthma and COPD - Comparison of response to SFC in elderly- versus younger- onset asthma, and COPD
Third Department of Internal Medicine, Wakayama Medical university0 个研究点目标入组 60 人开始时间: 2011年9月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
The results was reported as an original article. Am J Geriatric Soc 2012;60:1587-1588
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Asthma: History of smoking. COPD: Current smokers. Common criteria: 1, Diagnosed with non-COPD / non-asthma respiratory disorders and heart diseases. 2, Poor adherence. 3, Use inhaled, oral, and injection steroids within 8 weeks before enrollment. 4, Patients have hypersensitivity to salmeterol or fluticasone propionate, or suspected patient. 5, The patients who are inappropriate considered by physician
研究者
相似试验
已完成
3 期
Treatment Of Partial Reversible Chronic Obstructive Pulmonary DiseasePulmonary Disease, Chronic ObstructiveNCT00549146GlaxoSmithKline290
已完成
不适用
sefulness of salmeterol/fluticasone combination (SFC) therapy in preschool children with uncontrolled asthma treated with inhaled corticosteroid.Preschool children with asthmaJPRN-UMIN000006770Dokkyo Medical University50
终止
4 期
Salmeterol/Fluticasone 50/500 mcg Inhalation Powder Via Capsair vs Seretide Diskus 500 mcg Inhalation Powder in Patients With COPDCOPDNCT03363503Neutec Ar-Ge San ve Tic A.Ş64
撤回
1 期
A Study in Patients With Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered Via the ROTAHALER® Inhaler Relative to the DISKUS® InhalerAsthmaNCT02218762GlaxoSmithKline
已完成
4 期
Comparing Fluticasone-salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and SleepCOPDNCT00731770Milton S. Hershey Medical Center10